Gastric cancer diagnostics market to reach $2.78b by 2034

By product, the “reagents & consumables” segment held the largest share in 2024.

The global gastric cancer diagnostics market is expected to reach $2.78b by 2034, according to a Polaris Market Research report.

The sector’s expansion is attributed to the rising number of gastric cancer cases, leading to a higher demand for diagnostic services.

In addition, a growing emphasis on early detection through screening programmes is driving market growth.

By product, the “reagents & consumables” segment accounted for the largest market share in 2024.

“The industry is also benefiting from ongoing technological advancements, with newer, more precise, and less invasive diagnostic tools becoming available,” the report said.